Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of

Advancement highlights Everest’s potential in providing first-in-class therapies to global patients with glomerular disease SHANGHAI, Sept.…

Model Caitlin Kimpton shares ulcerative colitis journey

After having her large intestine removed, Caitlin Kimpton awaits two more major surgeries to help with…